Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.3072
Revised: March 15, 2010
Accepted: March 22, 2010
Published online: June 28, 2010
AIM: To develop the simple, rapid and sensitive dual-label time-resolved fluoroimmunoassay for pepsinogens in human serum.
METHODS: Based on two-site sandwich protocol, monoclonal antibodies (McAbs) against pepsinogen I (PG I) and PG II were co-coated in 96 microtitration wells, and tracer McAbs against PG I and PG II were labeled with europium (Eu) and samarium (Sm) chelate, respectively. Diluted serum samples of Eu3+- and Sm3+-McAbs were added into microtitration wells simultaneously. After washing, fluorescence of bound Sm3+ and Eu3+ tracers was detected.
RESULTS: The detection limit was 0.2 μg/L for PG I and 0.05 μg/L for PG II. The assay range was 5.0-320.0 μg/L for PG I and 1.0-55.0 μg/L for PG II. The average recovery rate was 102.7% for PG I and 98.8% for PG II. Sera from healthy controls and patients with gastric disease were analyzed. The PG detected by dual-label assay was in good agreement with that detected by single-label assay or by enzyme-linked immunosorbent assay.
CONCLUSION: Dual-label assay can provide high-throughput serological screening for gastric diseases.